MAG
DERM icon

Millrace Asset Group’s Journey Medical DERM Stock Holding History

Millrace Asset Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-81,070
Closed -$392K – 67
2022
Q1 		$392K Sell
81,070
-32,792
-29% -$164K 0.28% 67
2021
Q4 		$613K Buy
+113,862
New +$825K 0.36% 75

Other funds holding DERM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millrace Asset Group's DERM Position: Q2 2022 in Review

Millrace Asset Group sold out of Journey Medical (DERM) in Q2 2022, closing a stake of 81,070 shares — an estimated $392K sold.

Millrace Asset Group first reported a position in DERM in Q4 2021 and held it in 2 quarters. The position peaked at $613K in Q4 2021. 13 funds tracked by Wall St. Rank hold DERM as of Q2 2022.

  • Millrace Asset Group reported no remaining Journey Medical position as of Q2 2022 after selling out during the quarter.
  • Millrace Asset Group sold 81,070 Journey Medical shares in Q2 2022, an estimated $392K.
  • Millrace Asset Group first reported a position in Journey Medical in Q4 2021 and held it in 2 quarters.
  • Millrace Asset Group's Journey Medical position peaked at $613K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Journey Medical as of Q2 2022.

Based on Millrace Asset Group's 13F filing for Q2 2022, filed 28 Jul 2022.